Plasmacytoid dendritic cells delineate immunogenicity of influenza vaccine subtypes (Q45184856)

10 December 2017

Plasmacytoid dendritic cells delineate immunogenicity of influenza vaccine subtypes (English)

1 reference

10 December 2017

1 reference

0 references

1 reference

1

1 reference

10 December 2017

11

1 reference

10 December 2017

Yutaro Kumagai

4

0 references

Cevayir Coban

object named as

Cevayir Coban

8

0 references

Toshihiro Horii

object named as

Toshihiro Horii

9

0 references

Shizuo Akira

10

object named as

Shizuo Akira

1 reference

10 December 2017

Taiki Aoshi

2

1 reference

10 December 2017

Takeshi Tanimoto

3

1 reference

10 December 2017

Kouji Kobiyama

5

1 reference

10 December 2017

Takahiro Tougan

6

1 reference

10 December 2017

Kazuo Sakurai

7

1 reference

10 December 2017

language of work or name

English

0 references

publication date

1 March 2010

1 reference

Science Translational Medicine

10 December 2017

1 reference

10 December 2017

2

1 reference

10 December 2017

25

1 reference

10 December 2017

25ra24

1 reference

A Controlled Double-Blind Comparison of Reactogenicity, Immunogenicity, and Protective Efficacy of Whole-Virus and Split-Product Influenza Vaccines in Children

10 December 2017

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3000759

Mortality benefits of influenza vaccination in elderly people: an ongoing controversy

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3000759

Inactivated influenza virus vaccines in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3000759

Clinical effectiveness of influenza vaccination in persons younger than 65 years with high-risk medical conditions: the PRISMA study

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3000759

Translating innate immunity into immunological memory: implications for vaccine development

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3000759

Pattern recognition receptors and control of adaptive immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3000759

Toll or toll-free adjuvant path toward the optimal vaccine development

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3000759

Differential role of TLR- and RLR-signaling in the immune responses to influenza A virus infection and vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3000759

Inflammasome recognition of influenza virus is essential for adaptive immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3000759

Innate immune control of nucleic acid-based vaccine immunogenicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3000759

Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3000759

RIG-I-mediated antiviral responses to single-stranded RNA bearing 5'-phosphates

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3000759

The NLRP3 inflammasome mediates in vivo innate immunity to influenza A virus through recognition of viral RNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3000759

The intracellular sensor NLRP3 mediates key innate and healing responses to influenza A virus via the regulation of caspase-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3000759

Type I interferon as a powerful adjuvant for monocyte-derived dendritic cell development and activity in vitro and in Hu-PBL-SCID mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3000759

The role of alpha/beta and gamma interferons in development of immunity to influenza A virus in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3000759

Plasmacytoid dendritic cells in immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3000759

Clearance of influenza virus from the lung depends on migratory langerin+CD11b- but not plasmacytoid dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3000759

Plasmacytoid dendritic cells are dispensable during primary influenza virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3000759

Superior immunogenicity of inactivated whole virus H5N1 influenza vaccine is primarily controlled by Toll-like receptor signalling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3000759

Synthesis and in vitro characterization of antigen-conjugated polysaccharide as a CpG DNA carrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3000759

The inflammasome: a caspase-1-activation platform that regulates immune responses and disease pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3000759

Pre-existing immunity against swine-origin H1N1 influenza viruses in the general human population

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3000759

Assessment of seasonal influenza A virus-specific CD4 T-cell responses to 2009 pandemic H1N1 swine-origin influenza A virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3000759

Does Glycosylation as a modifier of Original Antigenic Sin explain the case age distribution and unusual toxicity in pandemic novel H1N1 influenza?

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3000759

Cellular immune responses in children and adults receiving inactivated or live attenuated influenza vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3000759

A clinical trial of a whole-virus H5N1 vaccine derived from cell culture.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3000759

Safety and immunogenicity of an inactivated adjuvanted whole-virion influenza A (H5N1) vaccine: a phase I randomised controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3000759

Priming with cold-adapted influenza A does not prevent infection but elicits long-lived protection against supralethal challenge with heterosubtypic virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3000759

Studies of Inactivated Influenza Virus Vaccines in Hospital Employees: Reactogenicity and Absenteeism

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3000759

TANK-binding kinase-1 delineates innate and adaptive immune responses to DNA vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3000759

Cryopyrin activates the inflammasome in response to toxins and ATP

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3000759

A Polysaccharide Carrier to Effectively Deliver Native Phosphodiester CpG DNA to Antigen-Presenting Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3000759

A polysaccharide carrier for immunostimulatory CpG DNAs to enhance cytokine secretion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3000759

10.1126/SCITRANSLMED.3000759

21 January 2018

Identifiers

DOI

1 reference

10 December 2017

1 reference